Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma - Concepedia

Concepedia

Publication | Open Access

Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

DOI Full Paper Access

461

Citations

22

References

2015

Year

Theodore S. Hong, Jennifer Y. Wo, Beow Y. Yeap, Edgar Ben‐Josef, Erin McDonnell, Lawrence S. Blaszkowsky, Eunice L. Kwak, Jill N. Allen, Jeffrey W. Clark, Lipika Goyal,

Journal of Clinical Oncology

Abstract

High-dose hypofractionated proton therapy demonstrated high LC rates for HCC and ICC safely, supporting ongoing phase III trials of radiation in HCC and ICC.

References

	Year	Citations

Page 1